Hamid Khoja

CIK: 0002010662

Transaction Breakdown

Open Market Buys (P)2 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

FBLG

FibroBiologics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

FBLG
FibroBiologics, Inc.
Sep 15, 2026
Award(A)
Direct
298.5K shares at avg. $1.68$500K
FBLG
FibroBiologics, Inc.
May 4, 2026
Award(A)
Stock Option (Right to Buy)
Direct
61.6K shares-
FBLG
FibroBiologics, Inc.
Mar 4, 2026
Purchase(P)
Direct
30K shares at avg. $0.38$11K
FBLG
FibroBiologics, Inc.
May 27, 2025
Purchase(P)
Direct
20K shares at avg. $0.84$17K
FBLG
FibroBiologics, Inc.
Mar 26, 2025
Award(A)
Stock Option (Right to Buy)
Direct
189K shares-
FBLG
FibroBiologics, Inc.
Dec 27, 2024
Award(A)
Stock Option (Right to Buy)
Direct
176.2K shares-

		Type	Shares	Price		Ownership
Sep 15, 2026	FBLG FibroBiologics, Inc.	Award(A)	298,508	$1.68	$500,001	Direct
May 4, 2026	FBLG FibroBiologics, Inc.	Award(A) Stock Option (Right to Buy)	61,607	-	-	Direct
Mar 4, 2026	FBLG FibroBiologics, Inc.	Purchase(P)	30,000	$0.38	$11,400	Direct
May 27, 2025	FBLG FibroBiologics, Inc.	Purchase(P)	20,000	$0.84	$16,800	Direct
Mar 26, 2025	FBLG FibroBiologics, Inc.	Award(A) Stock Option (Right to Buy)	189,000	-	-	Direct
Dec 27, 2024	FBLG FibroBiologics, Inc.	Award(A) Stock Option (Right to Buy)	176,200	-	-	Direct

1-6 of 6 transactions

About Khoja Hamid

Khoja Hamid (SEC CIK 0002010662) files insider reports with the SEC as Chief Scientific Officer of FibroBiologics, Inc. (FBLG).

Signal8 holds 6 ownership filings by Khoja Hamid, all Form 4s, filed between Dec 30, 2024 and Sep 15, 2026. Those filings report 6 transactions, from Dec 27, 2024 to Sep 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Khoja Hamid's filings is in HOUSTON, TX.

Recent filings by Khoja Hamid

Sep 15, 2026: Grant or award of FBLG shares (Form 4, code A).
May 4, 2026: Grant or award of FBLG derivative securities (Form 4, code A).
Mar 4, 2026: Open-market purchase of FBLG shares (Form 4, code P).
May 27, 2025: Open-market purchase of FBLG shares (Form 4, code P).
Mar 26, 2025: Grant or award of FBLG derivative securities (Form 4, code A).

Other insiders filing for FibroBiologics, Inc. (FBLG)

How to read Form 4 transaction codes